Promotional price valid on web orders only. Your contract pricing may differ. Interested in signing up for a dedicated account number?
Learn More

Claudin 19 Mouse anti-Human, Clone: 693202, Invitrogen™

Mouse Monoclonal Antibody

Manufacturer:  Invitrogen MA524317

Catalog No. PIMA524317


Add to cart

Description

Description

Reconstitute in sterile PBS to a final concentration of 0.5 mg/mL.

The product of this gene belongs to the claudin family. It plays a major role in tight junction-specific obliteration of the intercellular space, through calcium-independent cell-adhesion activity. Defects in this gene are the cause of hypomagnesemia renal with ocular involvement (HOMGO). HOMGO is a progressive renal disease characterized by primary renal magnesium wasting with hypomagnesemia, hypercalciuria and nephrocalcinosis associated with severe ocular abnormalities such as bilateral chorioretinal scars, macular colobomata, significant myopia and nystagmus. Alternatively spliced transcript variants encoding distinct isoforms have been identified for this gene. [provided by RefSeq, Jun 2010].
Specifications

Specifications

Claudin 19
Monoclonal
0.5 mg/mL
PBS with 5% trehalose and No Preservative
Q8N6F1
CLDN19, claudin 19, claudin-19
Mouse
IgG1
100 μg
-20° C, Avoid Freeze/Thaw Cycles
Primary
149461
Immunohistochemistry (Paraffin)
693202
Unconjugated
CLDN19
Lyophilized
CLDN19
NS0 mouse myeloma cell line transfected with human Claudin-19
Protein A/G
RUO
Antibody
Monoclonal
Human
Documents
Provide Content Correction

We continue to work to improve your shopping experience and your feedback regarding this content is very important to us. Please use the form below to provide feedback related to the content on this product.

Product Title

By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.

Cancel Submit